line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-110071428.571429,SYMPHONY.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.239286,SYMPHONY.NS
Normalized EBITDA,2025-03-31 00:00:00,3580000000.0,SYMPHONY.NS
Total Unusual Items,2025-03-31 00:00:00,-460000000.0,SYMPHONY.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-460000000.0,SYMPHONY.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Reconciled Depreciation,2025-03-31 00:00:00,220000000.0,SYMPHONY.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,8010000000.0,SYMPHONY.NS
EBITDA,2025-03-31 00:00:00,3120000000.0,SYMPHONY.NS
EBIT,2025-03-31 00:00:00,2900000000.0,SYMPHONY.NS
Net Interest Income,2025-03-31 00:00:00,-100000000.0,SYMPHONY.NS
Interest Expense,2025-03-31 00:00:00,100000000.0,SYMPHONY.NS
Interest Income,2025-03-31 00:00:00,,SYMPHONY.NS
Normalized Income,2025-03-31 00:00:00,2479928571.428571,SYMPHONY.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Total Expenses,2025-03-31 00:00:00,12870000000.0,SYMPHONY.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,SYMPHONY.NS
Diluted Average Shares,2025-03-31 00:00:00,68954354.0,SYMPHONY.NS
Basic Average Shares,2025-03-31 00:00:00,68954354.0,SYMPHONY.NS
Diluted EPS,2025-03-31 00:00:00,30.89,SYMPHONY.NS
Basic EPS,2025-03-31 00:00:00,30.89,SYMPHONY.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Net Income Common Stockholders,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,SYMPHONY.NS
Net Income,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Minority Interests,2025-03-31 00:00:00,,SYMPHONY.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Net Income Continuous Operations,2025-03-31 00:00:00,2130000000.0,SYMPHONY.NS
Tax Provision,2025-03-31 00:00:00,670000000.0,SYMPHONY.NS
Pretax Income,2025-03-31 00:00:00,2800000000.0,SYMPHONY.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,470000000.0,SYMPHONY.NS
Special Income Charges,2025-03-31 00:00:00,-460000000.0,SYMPHONY.NS
Other Special Charges,2025-03-31 00:00:00,,SYMPHONY.NS
Write Off,2025-03-31 00:00:00,,SYMPHONY.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-100000000.0,SYMPHONY.NS
Total Other Finance Cost,2025-03-31 00:00:00,,SYMPHONY.NS
Interest Expense Non Operating,2025-03-31 00:00:00,100000000.0,SYMPHONY.NS
Interest Income Non Operating,2025-03-31 00:00:00,,SYMPHONY.NS
Operating Income,2025-03-31 00:00:00,2890000000.0,SYMPHONY.NS
Operating Expense,2025-03-31 00:00:00,4860000000.0,SYMPHONY.NS
Other Operating Expenses,2025-03-31 00:00:00,2390000000.0,SYMPHONY.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,220000000.0,SYMPHONY.NS
Depreciation Income Statement,2025-03-31 00:00:00,220000000.0,SYMPHONY.NS
Selling General And Administration,2025-03-31 00:00:00,990000000.0,SYMPHONY.NS
Selling And Marketing Expense,2025-03-31 00:00:00,990000000.0,SYMPHONY.NS
General And Administrative Expense,2025-03-31 00:00:00,,SYMPHONY.NS
Rent And Landing Fees,2025-03-31 00:00:00,,SYMPHONY.NS
Gross Profit,2025-03-31 00:00:00,7750000000.0,SYMPHONY.NS
Cost Of Revenue,2025-03-31 00:00:00,8010000000.0,SYMPHONY.NS
Total Revenue,2025-03-31 00:00:00,15760000000.0,SYMPHONY.NS
Operating Revenue,2025-03-31 00:00:00,15760000000.0,SYMPHONY.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-3646408.839779,SYMPHONY.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.18232,SYMPHONY.NS
Normalized EBITDA,2024-03-31 00:00:00,2190000000.0,SYMPHONY.NS
Total Unusual Items,2024-03-31 00:00:00,-20000000.0,SYMPHONY.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-20000000.0,SYMPHONY.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Reconciled Depreciation,2024-03-31 00:00:00,260000000.0,SYMPHONY.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,6010000000.0,SYMPHONY.NS
EBITDA,2024-03-31 00:00:00,2170000000.0,SYMPHONY.NS
EBIT,2024-03-31 00:00:00,1910000000.0,SYMPHONY.NS
Net Interest Income,2024-03-31 00:00:00,-100000000.0,SYMPHONY.NS
Interest Expense,2024-03-31 00:00:00,100000000.0,SYMPHONY.NS
Interest Income,2024-03-31 00:00:00,178700000.0,SYMPHONY.NS
Normalized Income,2024-03-31 00:00:00,1496353591.160221,SYMPHONY.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Total Expenses,2024-03-31 00:00:00,10140000000.0,SYMPHONY.NS
Rent Expense Supplemental,2024-03-31 00:00:00,108400000.0,SYMPHONY.NS
Diluted Average Shares,2024-03-31 00:00:00,69062063.0,SYMPHONY.NS
Basic Average Shares,2024-03-31 00:00:00,69062063.0,SYMPHONY.NS
Diluted EPS,2024-03-31 00:00:00,21.43,SYMPHONY.NS
Basic EPS,2024-03-31 00:00:00,21.43,SYMPHONY.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Net Income Common Stockholders,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,SYMPHONY.NS
Net Income,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Minority Interests,2024-03-31 00:00:00,0.0,SYMPHONY.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Net Income Continuous Operations,2024-03-31 00:00:00,1480000000.0,SYMPHONY.NS
Tax Provision,2024-03-31 00:00:00,330000000.0,SYMPHONY.NS
Pretax Income,2024-03-31 00:00:00,1810000000.0,SYMPHONY.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,510000000.0,SYMPHONY.NS
Special Income Charges,2024-03-31 00:00:00,-20000000.0,SYMPHONY.NS
Other Special Charges,2024-03-31 00:00:00,27900000.0,SYMPHONY.NS
Write Off,2024-03-31 00:00:00,,SYMPHONY.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-100000000.0,SYMPHONY.NS
Total Other Finance Cost,2024-03-31 00:00:00,15600000.0,SYMPHONY.NS
Interest Expense Non Operating,2024-03-31 00:00:00,100000000.0,SYMPHONY.NS
Interest Income Non Operating,2024-03-31 00:00:00,178700000.0,SYMPHONY.NS
Operating Income,2024-03-31 00:00:00,1420000000.0,SYMPHONY.NS
Operating Expense,2024-03-31 00:00:00,4130000000.0,SYMPHONY.NS
Other Operating Expenses,2024-03-31 00:00:00,1980000000.0,SYMPHONY.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,260000000.0,SYMPHONY.NS
Depreciation Income Statement,2024-03-31 00:00:00,260000000.0,SYMPHONY.NS
Selling General And Administration,2024-03-31 00:00:00,670000000.0,SYMPHONY.NS
Selling And Marketing Expense,2024-03-31 00:00:00,670000000.0,SYMPHONY.NS
General And Administrative Expense,2024-03-31 00:00:00,419900000.0,SYMPHONY.NS
Rent And Landing Fees,2024-03-31 00:00:00,108400000.0,SYMPHONY.NS
Gross Profit,2024-03-31 00:00:00,5550000000.0,SYMPHONY.NS
Cost Of Revenue,2024-03-31 00:00:00,6010000000.0,SYMPHONY.NS
Total Revenue,2024-03-31 00:00:00,11560000000.0,SYMPHONY.NS
Operating Revenue,2024-03-31 00:00:00,11560000000.0,SYMPHONY.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,40915782.545742,SYMPHONY.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.237331,SYMPHONY.NS
Normalized EBITDA,2023-03-31 00:00:00,1713800000.0,SYMPHONY.NS
Total Unusual Items,2023-03-31 00:00:00,172400000.0,SYMPHONY.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,172400000.0,SYMPHONY.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,1164200000.0,SYMPHONY.NS
Reconciled Depreciation,2023-03-31 00:00:00,264500000.0,SYMPHONY.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,6672600000.0,SYMPHONY.NS
EBITDA,2023-03-31 00:00:00,1886200000.0,SYMPHONY.NS
EBIT,2023-03-31 00:00:00,1621700000.0,SYMPHONY.NS
Net Interest Income,2023-03-31 00:00:00,81700000.0,SYMPHONY.NS
Interest Expense,2023-03-31 00:00:00,102300000.0,SYMPHONY.NS
Interest Income,2023-03-31 00:00:00,198100000.0,SYMPHONY.NS
Normalized Income,2023-03-31 00:00:00,1032715782.545742,SYMPHONY.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,1164200000.0,SYMPHONY.NS
Total Expenses,2023-03-31 00:00:00,10704300000.0,SYMPHONY.NS
Rent Expense Supplemental,2023-03-31 00:00:00,88500000.0,SYMPHONY.NS
Diluted Average Shares,2023-03-31 00:00:00,69957000.0,SYMPHONY.NS
Basic Average Shares,2023-03-31 00:00:00,69957000.0,SYMPHONY.NS
Diluted EPS,2023-03-31 00:00:00,16.64,SYMPHONY.NS
Basic EPS,2023-03-31 00:00:00,16.64,SYMPHONY.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,1164200000.0,SYMPHONY.NS
Net Income Common Stockholders,2023-03-31 00:00:00,1164200000.0,SYMPHONY.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,SYMPHONY.NS
Net Income,2023-03-31 00:00:00,1164200000.0,SYMPHONY.NS
Minority Interests,2023-03-31 00:00:00,5400000.0,SYMPHONY.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,1158800000.0,SYMPHONY.NS
Net Income Continuous Operations,2023-03-31 00:00:00,1158800000.0,SYMPHONY.NS
Tax Provision,2023-03-31 00:00:00,360600000.0,SYMPHONY.NS
Pretax Income,2023-03-31 00:00:00,1519400000.0,SYMPHONY.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,61600000.0,SYMPHONY.NS
Special Income Charges,2023-03-31 00:00:00,-100000.0,SYMPHONY.NS
Other Special Charges,2023-03-31 00:00:00,100000.0,SYMPHONY.NS
Write Off,2023-03-31 00:00:00,,SYMPHONY.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,81700000.0,SYMPHONY.NS
Total Other Finance Cost,2023-03-31 00:00:00,14100000.0,SYMPHONY.NS
Interest Expense Non Operating,2023-03-31 00:00:00,102300000.0,SYMPHONY.NS
Interest Income Non Operating,2023-03-31 00:00:00,198100000.0,SYMPHONY.NS
Operating Income,2023-03-31 00:00:00,1134100000.0,SYMPHONY.NS
Operating Expense,2023-03-31 00:00:00,4031700000.0,SYMPHONY.NS
Other Operating Expenses,2023-03-31 00:00:00,592900000.0,SYMPHONY.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,264500000.0,SYMPHONY.NS
Depreciation Income Statement,2023-03-31 00:00:00,264500000.0,SYMPHONY.NS
Selling General And Administration,2023-03-31 00:00:00,1777400000.0,SYMPHONY.NS
Selling And Marketing Expense,2023-03-31 00:00:00,1438400000.0,SYMPHONY.NS
General And Administrative Expense,2023-03-31 00:00:00,339000000.0,SYMPHONY.NS
Rent And Landing Fees,2023-03-31 00:00:00,88500000.0,SYMPHONY.NS
Gross Profit,2023-03-31 00:00:00,5165800000.0,SYMPHONY.NS
Cost Of Revenue,2023-03-31 00:00:00,6672600000.0,SYMPHONY.NS
Total Revenue,2023-03-31 00:00:00,11838400000.0,SYMPHONY.NS
Operating Revenue,2023-03-31 00:00:00,11838400000.0,SYMPHONY.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,63812117.956065,SYMPHONY.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.278534,SYMPHONY.NS
Normalized EBITDA,2022-03-31 00:00:00,1777100000.0,SYMPHONY.NS
Total Unusual Items,2022-03-31 00:00:00,229100000.0,SYMPHONY.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,229100000.0,SYMPHONY.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1203100000.0,SYMPHONY.NS
Reconciled Depreciation,2022-03-31 00:00:00,241800000.0,SYMPHONY.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,5713800000.0,SYMPHONY.NS
EBITDA,2022-03-31 00:00:00,2006200000.0,SYMPHONY.NS
EBIT,2022-03-31 00:00:00,1764400000.0,SYMPHONY.NS
Net Interest Income,2022-03-31 00:00:00,-14400000.0,SYMPHONY.NS
Interest Expense,2022-03-31 00:00:00,89200000.0,SYMPHONY.NS
Interest Income,2022-03-31 00:00:00,89100000.0,SYMPHONY.NS
Normalized Income,2022-03-31 00:00:00,1037812117.956065,SYMPHONY.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1203100000.0,SYMPHONY.NS
Total Expenses,2022-03-31 00:00:00,8969700000.0,SYMPHONY.NS
Rent Expense Supplemental,2022-03-31 00:00:00,69100000.0,SYMPHONY.NS
Diluted Average Shares,2022-03-31 00:00:00,69957000.0,SYMPHONY.NS
Basic Average Shares,2022-03-31 00:00:00,69957000.0,SYMPHONY.NS
Diluted EPS,2022-03-31 00:00:00,17.2,SYMPHONY.NS
Basic EPS,2022-03-31 00:00:00,17.2,SYMPHONY.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1203100000.0,SYMPHONY.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1203100000.0,SYMPHONY.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,SYMPHONY.NS
Net Income,2022-03-31 00:00:00,1203100000.0,SYMPHONY.NS
Minority Interests,2022-03-31 00:00:00,-5500000.0,SYMPHONY.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1208600000.0,SYMPHONY.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1208600000.0,SYMPHONY.NS
Tax Provision,2022-03-31 00:00:00,466600000.0,SYMPHONY.NS
Pretax Income,2022-03-31 00:00:00,1675200000.0,SYMPHONY.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,57800000.0,SYMPHONY.NS
Special Income Charges,2022-03-31 00:00:00,-100000.0,SYMPHONY.NS
Other Special Charges,2022-03-31 00:00:00,100000.0,SYMPHONY.NS
Write Off,2022-03-31 00:00:00,,SYMPHONY.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-14400000.0,SYMPHONY.NS
Total Other Finance Cost,2022-03-31 00:00:00,14300000.0,SYMPHONY.NS
Interest Expense Non Operating,2022-03-31 00:00:00,89200000.0,SYMPHONY.NS
Interest Income Non Operating,2022-03-31 00:00:00,89100000.0,SYMPHONY.NS
Operating Income,2022-03-31 00:00:00,1379500000.0,SYMPHONY.NS
Operating Expense,2022-03-31 00:00:00,3255900000.0,SYMPHONY.NS
Other Operating Expenses,2022-03-31 00:00:00,397000000.0,SYMPHONY.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,241800000.0,SYMPHONY.NS
Depreciation Income Statement,2022-03-31 00:00:00,241800000.0,SYMPHONY.NS
Selling General And Administration,2022-03-31 00:00:00,1342300000.0,SYMPHONY.NS
Selling And Marketing Expense,2022-03-31 00:00:00,1015400000.0,SYMPHONY.NS
General And Administrative Expense,2022-03-31 00:00:00,326900000.0,SYMPHONY.NS
Rent And Landing Fees,2022-03-31 00:00:00,69100000.0,SYMPHONY.NS
Gross Profit,2022-03-31 00:00:00,4635400000.0,SYMPHONY.NS
Cost Of Revenue,2022-03-31 00:00:00,5713800000.0,SYMPHONY.NS
Total Revenue,2022-03-31 00:00:00,10349200000.0,SYMPHONY.NS
Operating Revenue,2022-03-31 00:00:00,10349200000.0,SYMPHONY.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,SYMPHONY.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,SYMPHONY.NS
Normalized EBITDA,2021-03-31 00:00:00,,SYMPHONY.NS
Total Unusual Items,2021-03-31 00:00:00,,SYMPHONY.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,SYMPHONY.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,SYMPHONY.NS
Reconciled Depreciation,2021-03-31 00:00:00,,SYMPHONY.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,SYMPHONY.NS
EBITDA,2021-03-31 00:00:00,,SYMPHONY.NS
EBIT,2021-03-31 00:00:00,,SYMPHONY.NS
Net Interest Income,2021-03-31 00:00:00,,SYMPHONY.NS
Interest Expense,2021-03-31 00:00:00,,SYMPHONY.NS
Interest Income,2021-03-31 00:00:00,90300000.0,SYMPHONY.NS
Normalized Income,2021-03-31 00:00:00,,SYMPHONY.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,SYMPHONY.NS
Total Expenses,2021-03-31 00:00:00,,SYMPHONY.NS
Rent Expense Supplemental,2021-03-31 00:00:00,58700000.0,SYMPHONY.NS
Diluted Average Shares,2021-03-31 00:00:00,,SYMPHONY.NS
Basic Average Shares,2021-03-31 00:00:00,,SYMPHONY.NS
Diluted EPS,2021-03-31 00:00:00,,SYMPHONY.NS
Basic EPS,2021-03-31 00:00:00,,SYMPHONY.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,SYMPHONY.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,SYMPHONY.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,SYMPHONY.NS
Net Income,2021-03-31 00:00:00,,SYMPHONY.NS
Minority Interests,2021-03-31 00:00:00,-400000.0,SYMPHONY.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,SYMPHONY.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,SYMPHONY.NS
Tax Provision,2021-03-31 00:00:00,,SYMPHONY.NS
Pretax Income,2021-03-31 00:00:00,,SYMPHONY.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,SYMPHONY.NS
Special Income Charges,2021-03-31 00:00:00,,SYMPHONY.NS
Other Special Charges,2021-03-31 00:00:00,70700000.0,SYMPHONY.NS
Write Off,2021-03-31 00:00:00,70000000.0,SYMPHONY.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,SYMPHONY.NS
Total Other Finance Cost,2021-03-31 00:00:00,13400000.0,SYMPHONY.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,SYMPHONY.NS
Interest Income Non Operating,2021-03-31 00:00:00,90300000.0,SYMPHONY.NS
Operating Income,2021-03-31 00:00:00,,SYMPHONY.NS
Operating Expense,2021-03-31 00:00:00,,SYMPHONY.NS
Other Operating Expenses,2021-03-31 00:00:00,,SYMPHONY.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,SYMPHONY.NS
Depreciation Income Statement,2021-03-31 00:00:00,,SYMPHONY.NS
Selling General And Administration,2021-03-31 00:00:00,,SYMPHONY.NS
Selling And Marketing Expense,2021-03-31 00:00:00,,SYMPHONY.NS
General And Administrative Expense,2021-03-31 00:00:00,336500000.0,SYMPHONY.NS
Rent And Landing Fees,2021-03-31 00:00:00,58700000.0,SYMPHONY.NS
Gross Profit,2021-03-31 00:00:00,,SYMPHONY.NS
Cost Of Revenue,2021-03-31 00:00:00,,SYMPHONY.NS
Total Revenue,2021-03-31 00:00:00,,SYMPHONY.NS
Operating Revenue,2021-03-31 00:00:00,,SYMPHONY.NS
